Can you provide the last earnings date for CORE LABORATORIES INC?
CORE LABORATORIES INC (CLB) last reported earnings on 2/4/2026.
NYSE:CLB • US21867A1051
Past quarterly earnings results for CORE LABORATORIES INC (CLB), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.21 | 0.19 | 10.20% | -4.55% | 138.255M | 132.41M | 4.41% | 6.98% |
| Q3 2025 | 0.22 | 0.19 | 12.86% | -12.00% | 134.521M | 132.61M | 1.44% | 0.09% |
| Q2 2025 | 0.19 | 0.19 | -0.33% | -13.64% | 130.159M | 130.13M | 0.02% | -0.32% |
| Q1 2025 | 0.14 | 0.15 | -4.67% | -26.32% | 123.585M | 126.01M | -1.92% | -4.67% |
| Q4 2024 | 0.22 | 0.22 | -0.26% | 15.79% | 129.237M | 133.76M | -3.38% | 0.80% |
| Q3 2024 | 0.25 | 0.23 | 7.15% | 13.64% | 134.397M | 135.38M | -0.73% | 7.22% |
| Q2 2024 | 0.22 | 0.21 | 5.59% | 4.76% | 130.577M | 133.15M | -1.93% | 2.11% |
| Q1 2024 | 0.19 | 0.16 | 20.48% | - | 129.637M | 125.69M | 3.14% | 1.00% |
| Q4 2023 | 0.19 | 0.19 | -2.24% | -5.00% | 128.21M | 129.05M | -0.65% | 0.48% |
| Q3 2023 | 0.22 | 0.22 | -1.10% | 22.22% | 125.343M | 131.27M | -4.52% | -0.52% |
| Q2 2023 | 0.21 | 0.20 | 4.22% | 75.00% | 127.881M | 132.77M | -3.68% | 5.77% |
| Q1 2023 | 0.19 | 0.16 | 19.06% | 137.50% | 128.356M | 127.18M | 0.92% | 11.32% |
| Q4 2022 | 0.20 | 0.20 | 1.18% | - | 127.6M | 131.64M | -3.07% | 2.00% |
| Q3 2022 | 0.18 | 0.15 | 19.15% | - | 126M | 127.08M | -0.85% | 6.78% |
| Q2 2022 | 0.12 | 0.14 | -12.88% | -33.33% | 120.9M | 122.56M | -1.35% | 1.85% |
| Q1 2022 | 0.08 | 0.09 | -12.48% | -46.67% | 115.3M | 117.29M | -1.70% | 6.37% |
| Q4 2021 | 0.20 | 0.20 | -1.43% | 11.11% | 125.1M | 123.59M | 1.22% | 10.03% |
| Q3 2021 | 0.18 | 0.19 | -4.75% | 12.50% | 118M | 123.86M | -4.73% | 11.95% |
| Q2 2021 | 0.18 | 0.19 | -7.08% | 28.57% | 118.7M | 120.47M | -1.47% | 2.59% |
| Q1 2021 | 0.15 | 0.13 | 13.87% | -51.61% | 108.4M | 111.8M | -3.04% | -28.87% |
| Q4 2020 | 0.18 | 0.16 | 15.35% | - | 113.7M | 110.07M | 3.30% | - |
| Q3 2020 | 0.16 | 0.15 | 8.16% | - | 105.4M | 113.7M | -7.30% | - |
| Q2 2020 | 0.14 | 0.10 | 40.68% | - | 115.7M | 116.51M | -0.70% | - |
| Q1 2020 | 0.31 | 0.34 | -8.38% | - | 152.4M | 152.95M | -0.36% | - |
Notes
CORE LABORATORIES INC (CLB) last reported earnings on 2/4/2026.
CORE LABORATORIES INC (CLB) beat EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, CORE LABORATORIES INC (CLB) has beaten EPS estimates in 2 out of 4 releases.